Bär & Karrer Advised Eppendorf on its Investment in BigOmics Analytics

Eppendorf, a leading life science company that develops, produces and distributes products and services for the use in laboratories worldwide, made an investment in BigOmics Analytics, a Swiss biodata analytics start-up company, as part of their Pre-Series A financing round.

Bär & Karrer acted as legal advisor to Eppendorf in this transaction. The team was led by Christoph Neeracher and Raphael Annasohn und further included Adrian Zampieri and Lazar Lepir (both M&A) as well as Thomas Stoltz (Notarial Services).